Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: LEUKEMIA & LYMPHOMA SOCIETY · Firm: ROPES & GRAY, LLP
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 health-related appropriations at DoD (H.R. 5631/H.R. 5385)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: ROPES & GRAY, LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2007 · mid_year · MT
Legislation regarding funding for brain tumor research.
Legislation regarding NIH Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| American Society of Clinical Oncology, Inc. |
| 5 |
| 2002–2005 |
| CANCER LEADERSHIP COUNCIL | 5 | 2002–2006 |
| SUPERGEN | 5 | 2002–2004 |
| ABBOTT LABORATORIES | 4 | 2002–2003 |
| CELGENE CORP | 4 | 2002–2004 |
| MULTIPLE MYELOMA RESEARCH FOUNDATION | 4 | 2003–2005 |
| ELI LILLY & CO | 3 | 2002–2003 |
| JOHNSON & JOHNSON/ORTHO BIOTECH | 3 | 2002–2004 |
| NOVARTIS PHARMACEUTICAL CORP | 3 | 2002–2003 |
| BRISTOL MYERS SQUIBB CO | 2 | 2002–2004 |
| COUNCIL OF PARENT ATTORNEYS & ADVOCATES | 2 | 2003 |
| MERCK & CO | 2 | 2005 |
| PFIZER | 2 | 2002–2003 |
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 Defense/Military Quality of Life Appropriations (H.R. 5631/H.R. 5385)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: NORTH AMERICAN BRAIN TUMOR COALITION · Firm: ROPES & GRAY, LLP
FY 2007 NIH Appropriations (H.R. 5647/S.3708)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
Client: CYSTIC FIBROSIS FOUNDATION · Firm: ROPES & GRAY, LLP
Funding for Cystic Fibrosis research (H.R. 5647/S. 3708)
Enhancing Drug Safety and Innovation Act of 2006
Client: CYSTIC FIBROSIS FOUNDATION · Firm: ROPES & GRAY, LLP
National Institutes of Health Reform Act (H.R. 6164) Enhancing Drug Safety and Innovation Act (S. 3807)
To designate the facility of the United States Postal Service located at 3131 Arch Airport Road in Stockton, California, as the "Norman Shumway Post Office Building".
Client: NATL COALITION OF CANCER SURVIVORSHIP · Firm: ROPES & GRAY, LLP
H.R. 5465, the Comprehensive Cancer Care Improvement Act
To designate the facility of the United States Postal Service located at 3131 Arch Airport Road in Stockton, California, as the "Norman Shumway Post Office Building".
Client: NATL COALITION OF CANCER SURVIVORSHIP · Firm: ROPES & GRAY, LLP
H.R. 5465, the Comprehensive Cancer Care Improvement Act
Local Control of Cellular Towers Act
Client: LEUKEMIA & LYMPHOMA SOCIETY · Firm: ROPES & GRAY, LLP
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 health-related appropriations at DoD (H.R. 5631/H.R. 5385)
Local Control of Cellular Towers Act
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: ROPES & GRAY, LLP
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 Defense/Military Quality of Life Appropriations (H.R. 5631/H.R. 5385)
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: NORTH AMERICAN BRAIN TUMOR COALITION · Firm: ROPES & GRAY, LLP
FY 2007 NIH Appropriations (H.R. 5647/S.3708)
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: ROPES & GRAY, LLP
Funding for Cystic Fibrosis research (H.R. 5647/S. 3708)
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: LEUKEMIA & LYMPHOMA SOCIETY · Firm: ROPES & GRAY, LLP
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 health-related appropriations at DoD (H.R. 5631/H.R. 5385)
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: ROPES & GRAY, LLP
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 Defense/Military Quality of Life Appropriations (H.R. 5631/H.R. 5385)
2007 · mid_year · MT
Legislation regarding comprehensive Cancer Care Improvement.
Legislation regarding comprehensive Cancer Care Improvement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2007 · mid_year · MT
Legislation regarding NIH Appropriations Legislation regarding CDC Appropriations Legislation regarding health-related appropriations at DOD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2007 · mid_year · MT
Legislation regarding National Institutes of Health Legislation regarding Enhancing Drug Safety and Innovation
Legislation regarding Funding for Cystic Fibrosis research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2006 · year_end · YY
FY 2007 NIH Appropriations (H.R. 5647/S.3708)
Funding for brain tumor research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATL COALITION OF CANCER SURVIVORSHIP via ROPES & GRAY, LLP
2006 · year_end · YY
H.R. 5465, the Comprehensive Cancer Care Improvement Act
H.R. 5465, the Comprehensive Cancer Care Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2006 · year_end · YY
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 Defense/Military Quality of Life Appropriations (H.R. 5631/H.R. 5385)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2006 · year_end · YY
FY 2007 NIH appropriations (H.R. 5647/S. 3708) FY 2007 CDC appropriations (H.R. 5647/ S. 3708) FY 2007 health-related appropriations at DoD (H.R. 5631/H.R. 5385)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2006 · year_end · YY
National Institutes of Health Reform Act (H.R. 6164) Enhancing Drug Safety and Innovation Act (S. 3807)
Funding for Cystic Fibrosis research (H.R. 5647/S. 3708)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via ROPES & GRAY, LLP
2006 · year_end · YY
Stem Cell Research Enhancement Act (H.R. 810) National Institutes of Health Reform Act (H.R. 6164)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTIPLE MYELOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via ROPES & GRAY, LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATL COALITION OF CANCER SURVIVORSHIP via ROPES & GRAY, LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via ROPES & GRAY, LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTIPLE MYELOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via ROPES & GRAY, LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO via ROPES & GRAY, LLP
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATL COALITION OF CANCER SURVIVORSHIP via ROPES & GRAY, LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO via ROPES & GRAY, LLP
2005 · mid_year · RR
NATL COALITION OF CANCER SURVIVORSHIP via ROPES & GRAY, LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELGENE CORP via ROPES & GRAY, LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERGEN via ROPES & GRAY, LLP
2004 · year_end · YT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via ROPES & GRAY, LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON/ORTHO BIOTECH via ROPES & GRAY, LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTIPLE MYELOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA LP via ROPES & GRAY, LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB CO via ROPES & GRAY, LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERGEN via ROPES & GRAY, LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via ROPES & GRAY, LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON/ORTHO BIOTECH via ROPES & GRAY, LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELGENE CORP via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & CO via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATL COALITION OF CANCER SURVIVORSHIP via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERGEN via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA LP via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL OF PARENT ATTORNEYS & ADVOCATES via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ROPES & GRAY, LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNCIL OF PARENT ATTORNEYS & ADVOCATES via ROPES & GRAY, LLP
2003 · year_end · RR
NOVARTIS PHARMACEUTICAL CORP via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY & CO via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA LP via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATL COALITION OF CANCER SURVIVORSHIP via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTIPLE MYELOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2003 · year_end · RR
CYSTIC FIBROSIS FOUNDATION via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERGEN via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELGENE CORP via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA LP via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATL COALITION OF CANCER SURVIVORSHIP via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS PHARMACEUTICAL CORP via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN BRAIN TUMOR COALITION via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERGEN via ROPES & GRAY, LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB CO via ROPES & GRAY, LLP
2002 · year_end · RR
JOHNSON & JOHNSON/ORTHO BIOTECH via ROPES & GRAY, LLP
2002 · year_end · RR
ELI LILLY & CO via ROPES & GRAY, LLP
2002 · year_end · RR
2002 · year_end · RR
LEUKEMIA & LYMPHOMA SOCIETY via ROPES & GRAY, LLP
2002 · year_end · RR
ASTRAZENECA LP via ROPES & GRAY, LLP
2002 · year_end · RR
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via ROPES & GRAY, LLP
2002 · year_end · RR
CELGENE CORP via ROPES & GRAY, LLP
2002 · year_end · RR
ABBOTT LABORATORIES via ROPES & GRAY, LLP
2002 · year_end · RR
NOVARTIS PHARMACEUTICAL CORP via ROPES & GRAY, LLP
2002 · year_end · RR